Conference Reports for NATAP

The International Liver Congress™ EASL - European Association for the Study of the Liver Aug 27-29 Digital ILC 2020 Back

Adherence & DAAs: how much is necessary to Achieve SVR: 75% in 1 study Achieves SVR & 50% in 2nd Study Achieves >90% SVR rate       75% adherence was adequate for SVR in this study from Canada at EASL   EASL Efficacy of Sofosbuvir/Velpatasvir (S/V): Impact of Treatment Adherence - (08/27/20)   The International Liver Congress EASL - European Association for the Study of the Liver 2020 Aug 27-29 Digital ILC 2020   In this study from Abbvie reported in 2017 at AASLD, adherence was defined as <80%>, take a look at the study report, "adherence rates as low as 50% correlate with predicted chance for SVR12 of at least 90%.....   Adherence to Pangenotypic Glecaprevir/Pibrentasvir Treatment and SVR12 in HCV-infected Patients: An Integrated Analysis of the Phase 2/3 Clinical Trial Program